fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

CHMP adoptes positive opinion, for Tepezza (teprotumumab) for treatment of adults with moderate to severe thyroid eye disease – Amgen

Written by | 12 Jul 2025

The EMA has recommended granting a marketing authorisation in the European Union (EU) for Tepezza (teprotumumab), for the treatment of adults with moderate to severe thyroid eye disease…. read more.

FDA approves Susvimo (ranibizumab injection) for diabetic retinopathy – Roche

Written by | 6 Jul 2025

Roche announced that the FDA has approved Susvimo (ranibizumab injection) 100 mg/mL for the treatment of diabetic retinopathy (DR), a potentially blinding condition that affects almost 10 million… read more.

Evidence gaps remain for AI eye imaging devices approved for patient care

Written by | 25 Jun 2025

Regulator-approved AI models used in eye care vary widely in providing evidence for clinical performance and lack transparency about training data, including details of gender, age and ethnicity,… read more.

Clearside to showcase Suprachoroidal Platform progress across three phase 3 programs at CTS 2025

Written by | 18 Jun 2025

Clearside Biomedical, Inc, a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced  that the use of its… read more.

Eye wear breakthrough: MXene-coated lenses for safer and smarter wearables

Written by | 9 Jun 2025

With recent advancements in technology, the Internet of Things and wireless devices are in high demand. However, these innovations also raise concerns about prolonged exposure to electromagnetic radiation… read more.

For eye infections, delayed doctor visits and extent of damage affect vision outcomes

Written by | 7 May 2025

Even though microbial keratitis is a preventable cause of blindness, it’s a complex infection to treat, and many patients have lasting vision impairment. Previous studies have identified several… read more.

Advances in corneal healing research drive new treatments for rare eye diseases

Written by | 7 Mar 2025

The Ocular Neurobiology laboratory at the Institute for Neurosciences, a joint center of Miguel Hernández University (UMH) in Elche and the Spanish National Research Council (CSIC), is participating in the… read more.

Early study shows promise for retinal-surgery robot invented at the University of Utah

Written by | 4 Mar 2025

When even the most highly trained surgeons perform procedures on the retina—one of the smallest, most delicate parts of the human body—the stakes are high. Surgeons must account… read more.

Syringe lubricants – a little-known aspect of injection preparation

Written by | 21 Nov 2024

Plastic syringes that are widely-used for administration of medications, require lubrication with silicone oil in order to work smoothly. However, silicone oil can migrate into the drug solution… read more.

Why ready-to-administer syringes improve clinical care

Written by | 20 Nov 2024

The provision of ready-to-administer bevacizumab syringes makes administration safer and quicker but finding a source of suitable syringes remains a challenge, says Dr Philip Chennell (Pharmacy Quality Control… read more.

How the syringe lubricant interacts with the drug inside it

Written by | 19 Nov 2024

Storage of bevacizumab injection solution in cross-linked silicone syringes was associated with less particle formation than when conventional polypropylene syringes were used, according to Dr Philip Chennell (Pharmacy… read more.

Why syringe type matters for intravitreal injections

Written by | 18 Nov 2024

Plastic syringes that are widely-used for administration of medications, require lubrication with silicone oil in order to work smoothly. However, silicone oil can migrate into the drug solution… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.